PhRMA, BIO Open Fire On FDA's Biosimilars Guidance
Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Association are leading an attack by innovator drugmakers on the U.S. Food and Drug Administration's most recent biosimilars guidance, saying in...To view the full article, register now.
Already a subscriber? Click here to view full article